Φορτώνει......
The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patients
Glioblastoma Multiforme (GBM) is the most common type of brain tumor and it is uniformly fatal. The community standard of treatment for this disease is gross or subtotal resection of the tumor, followed by radiation and temozolomide. At recurrence bevacizumab can be added for increased progression f...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Hum Vaccin Immunother |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Taylor & Francis
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4514075/ https://ncbi.nlm.nih.gov/pubmed/25625931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21645515.2014.983002 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|